childhood acute myeloid leukemia
Showing 1 - 25 of >10,000
DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
- +8 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Jul 12, 2022
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)
Recruiting
- Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 20, 2022
Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in
Suspended
- Juvenile Myelomonocytic Leukemia
- +27 more
- CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid
Completed
- Minimal Residual Disease
- +3 more
- Daratumumab
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Mar 2, 2022
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Recruiting
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +9 more
- etoposide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 19, 2022
Childhood Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia Trial in Oslo,
Recruiting
- Childhood Non-Hodgkin Lymphoma
- +2 more
- Goal Management Training (GMT)
- Brain Health Workshop (BHW)
-
Oslo, Norway
- +2 more
May 25, 2022
CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)
Not yet recruiting
- CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
- +3 more
- (no location specified)
Nov 14, 2022
Acute Lymphoid Leukemia, Acute Myeloid Leukemia in Children Trial in Tours (Biological sampling in patients, Biological sampling
Not yet recruiting
- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia in Children
- Biological sampling in patients
- Biological sampling in control patients
-
Tours, France
- +2 more
Mar 17, 2023
Cancer Survivor, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission Trial in
Completed
- Cancer Survivor
- +3 more
- Educational Intervention
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 10, 2021
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +23 more
- treosulfan
- +7 more
-
Denver, Colorado
- +2 more
Jun 17, 2021
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Duarte (Best Practice, Internet-Based
Recruiting
- Acute Leukemia
- +3 more
- Best Practice
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023
AML, Childhood Trial in United States (CD33*CD3 BsAb)
Active, not recruiting
- AML, Childhood
- CD33*CD3 BsAb
-
Birmingham, Alabama
- +12 more
Jan 12, 2023
Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood Trial in United States (AC220, Cytarabine,
Completed
- Lymphoblastic Leukemia, Acute, Childhood
- Myelogenous Leukemia, Acute, Childhood
- AC220
- +3 more
-
Los Angeles, California
- +10 more
Mar 24, 2022
Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6) Trial in
Completed
- Childhood Acute Basophilic Leukemia
- +14 more
- asparaginase
- +5 more
-
Phoenix, Arizona
- +96 more
Jan 20, 2022
AML, Childhood Trial in United States (Nivolumab, 5-azacytidine)
Active, not recruiting
- AML, Childhood
-
Los Angeles, California
- +11 more
Oct 10, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +46 more
- Fludarabine
- +8 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 10, 2021
Acute Myeloid Leukemia Trial in Antalya
Recruiting
- Acute Myeloid Leukemia
-
Antalya, TurkeyAntalya Training and Research Hospital
Jul 29, 2023
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)
Recruiting
- Acute Myeloid Leukemia Refractory
- Acute Myeloid Leukemia, in Relapse
- anti Tim-3/CD123 CAR-T cell therapy
-
Xuzhou, Jiangsu, ChinaKailin Xu
Nov 4, 2023
Patients With Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia, Adult
-
Freiburg, CA, GermanyMedical Center- University of Freiburg
Aug 4, 2023
Frequency and Risk Factors of Acute Myeloid Leukemia
Not yet recruiting
- Myeloid Leukemia
- Bone marrow aspirite for diagnosis
- (no location specified)
Mar 15, 2023
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +13 more
- Sirolimus
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 2, 2023